Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved by UKCA for NHS & Private UK Clinics
05 déc. 2024 04h02 HE
|
Magstim EGI
UKCA Approves Magstim Horizon Inspire TMS for NHS & Private UK Clinics. UK Made System for Patient Treatment of MDD, OCD and Decreasing Anxiety.
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
14 nov. 2024 07h00 HE
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evaluate proprietary aerosol delivery...
FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression
12 nov. 2024 08h11 HE
|
Magstim EGI
FDA clears Magstim INSPIRE Transcranial Magnetic Stimulation TMS system to treat patients with Depression, OCD, Anxious Depression
Two in Five Americans Say Their Mood Worsens in Winter; 29% Say “Falling Back” Hurts Their Mental Health
30 oct. 2024 10h00 HE
|
American Psychiatric Association
Washington, D.C., Oct. 30, 2024 (GLOBE NEWSWIRE) -- As the nation “falls back” to standard time, Americans are twice as likely to say their mood declines in the winter (41%) as they are to say it...
Nexstim Receives NBS System 5 Order from European Customer
02 oct. 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 2 October 2024 at 9 AM (EEST) Nexstim Receives NBS System 5 Order from European Customer Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS...
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
03 sept. 2024 07h05 HE
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and expected completion of 6-month open-label...
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
03 sept. 2024 07h00 HE
|
GH Research PLC
DUBLIN, Ireland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
Anxiety Disorders and Depression Treatment Global Market Report 2024-2032: Sturdy Medication Pipelines to Support Development, Economic Cost of Mental Illnesses to Drive Demand
30 août 2024 04h15 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Anxiety Disorders and Depression Treatment Global Market Report, Forecast by Product, Indication, Country and Company Analysis 2024-2032" report has...
Solace Psychology Announce New Anxiety and Depression Counselling Services in Melbourne
28 août 2024 09h00 HE
|
Solace Psychology
Carlton North, VIC, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Solace Psychology, regarded locally as the best psychologist melbourne, is happy to announce the launch of its anxiety and depression...
Digital Health App Data is used for Award-winning study that demonstrates correlation between temperature and depression
25 juil. 2024 09h13 HE
|
juli
Boston, July 25, 2024 (GLOBE NEWSWIRE) -- Dr. Pip Clery from University College London (UCL) has been awarded the 2024 Royal College of Psychiatrists International Congress poster prize in the...